Christoph Grunig's Contact Details

Christoph Grunig's Company Details

Microsynth AG

Balgach, St. Gallen, Switzerland • 47 Employees
Research

Microsynth (founded in 1989) is a leading company in Europe in the field of DNA/RNA syntheses & analyses. The main activities are divided into the following three business areas:1. DNA/RNA SYNTHESES›DNA/RNA oligonucleotides (unmodified, modified, various purity grades) for various R&D applications › Primers and probes (e.g. OEM kit production) for molecular diagnostics › antisense oligonucleotides as well as siRNAs for drug discovery2. DNA/RNA ANALYSES AND SEQUENCING› DNA Sanger sequencing of all types (incl. GMP sequencing) › Next generation sequencing (de novo & re-sequencing at the genome level, RNA-Seq, metagenome and amplicon sequencing, bioinformatics, etc.)› PCR, qPCR and digital PCR › Genotyping (fragment length analysis, cell line characterization, STR marker development, GBS)› DNA/RNA isolations (all sources, including high-throughput format)3. CONTRACT RESEARCH/OUTSOURCING› Assay establishment & validation (e.g. IVD, animal and food diagnostics)› Biological testing (e.g. lot release mRNA vaccines)› Gene editing/gene therapy (e.g. CRISPR on/off target GxP analyses, rAAV characterization)Microsynth employs >100 people and has branch offices in Germany (Microsynth Seqlab), France (Microsynth France), Austria (Microsynth Austria) and Switzerland (ecogenics). Microsynth is ISO 9001:2015-, ISO 13485:2016- (oligonucleotide synthesis, kit production), ISO/IEC 17025:2017 (STS 0429) - (NGS, Sanger sequencing, fragment length analysis) and GMP certified (Sanger sequencing).